Abstract
Nearly half of all olfactory dysfunction (OD) clinical trials since 2010 are COVID-19-related. COVID-19-related OD trials are published significantly faster than COVID-19-unrelated trials. High-quality clinical trials and publications are crucial to discovering effective treatments.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have